Literature DB >> 8856815

Use of stimulants in the medically ill.

P S Masand1, G E Tesar.   

Abstract

This article discusses the use of psychostimulants, such as dextroamphetamine, methylphenidate, and pemoline, in a variety of illnesses, including depression in the medically ill, cancer, HIV, and AIDS. The chemistry and pharmacology, side effects, drug interactions, dosing, and abuse potential also are reviewed.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8856815     DOI： 10.1016/s0193-953x(05)70304-x

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  19 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

3.  Cancer-related depression and potential pharmacologic therapies.

Authors:  Aimee Ginsburg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

Review 4.  Psychopharmacology in psycho-oncology.

Authors:  Rosangela Caruso; Luigi Grassi; Maria Giulia Nanni; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

5.  Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Authors:  Brandi R Page; Edward G Shaw; Lingyi Lu; David Bryant; David Grisell; Glenn J Lesser; Drew C Monitto; Michelle J Naughton; Stephen R Rapp; Steven R Savona; Sunjay Shah; Doug Case; Michael D Chan
Journal:  Neuro Oncol       Date:  2015-05-12       Impact factor: 12.300

6.  Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

Authors:  Amanda R Moraska; Amit Sood; Shaker R Dakhil; Jeff A Sloan; Debra Barton; Pamela J Atherton; Jason J Suh; Patricia C Griffin; David B Johnson; Aneela Ali; Peter T Silberstein; Steven F Duane; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 7.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

8.  Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.

Authors:  Bruno Gagnon; Graeme Low; Gil Schreier
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

9.  Using Psychostimulants to Treat Depression in the Medically Ill.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 10.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.